Massivemarkets

NXTS

Nexentis Technologies Inc. Common Stock

Nasdaq · usd

$1.83-0.16 (-8.04%)
As of 1:04:37 PM EST on Nov 17, 2026 · 15-minute delayed

Nexentis Technologies Inc. Common Stock (NXTS) trades at $1.83 (-8.04%) as of 1:04:37 PM EST on Nov 17, 2026, -41.29% over the past month. Market cap is $945.46K, with 1.0 days to cover in short interest.

Stock performance

How Nexentis Technologies Inc. Common Stock (NXTS) stock has performed from one day to one year, with its 52-week range.

-4.72%
-$0.09 over 1D
$1.83$1.86$1.88$1.919:35 AM10:15 AM11:35 AM12:55 PM1:05 PM$1.82
1D
-5.53%
1W
-26.56%
1M
-41.29%
YTD
-94.79%
1Y
-94.79%
52-wk range
$1.82 – $119.00

Key statistics

Today's trading snapshot for NXTS: day range, open, previous close, volume and market cap.

Day range
$1.82 – $1.92
Open
$1.92
Prev close
$1.99
Volume
4.39K
Market cap
$945.46K
Shares out
475.1K

Valuation and profitability ratios: P/E, P/S, ROE

Valuation and profitability ratios for Nexentis Technologies Inc. Common Stock: P/E, P/S, P/B, ROE and more.

P/E
—
P/S
524.99
P/B
0.46
P/FCF
—
ROE
-755.3%
ROA
-92.5%
Debt/Equity
0.18
Div yield
0.00%

As of Nov 13, 2026

8-K filings

Material corporate events Nexentis Technologies Inc. Common Stock has disclosed to the SEC on Form 8-K.

  • Equity compensation grantNov 10, 2026

    On November 9, 2026, Nexentis Technologies Inc. (the "Company") issued 72,000 shares of common stock to consultants in consideration of various investor relations and business development services provided to the Company. The issuance of such shares was exempt from registration under the Securities Act of 1933, as amended, in reliance on Section 4(a)(2) thereof as transactions by an issuer not involving a public offering.

  • Charter amendmentNov 6, 2026

    The Company filed with the Secretary of State of the State of Nevada a Certificate of Amendment to its Articles of Incorporation, as amended ... to effect the Reverse Stock Split.

  • Equity compensation grantOct 19, 2026

    On October 15, 2026, Nexentis Technologies Inc. issued ... 51,000 shares of common stock to a consultant for accounting and controller services ...; (ii) 101,549 shares ... to David Palach, its Chief Executive Officer; (iii) 51,000 shares ... to Lital Barda, its Chief Financial Officer; (iv) an aggregate of 208,639 shares ... to the Company's directors, in each case under its 2022 Share Incentive Plan.

  • On August 31, 2026, Nexentis Technologies Inc. received a letter from the Listing Qualifications Staff of The Nasdaq Capital Market notifying the Company that its stockholders' equity was no longer in compliance with Nasdaq Listing Rule 5550(b)(1), which requires listed companies to maintain stockholders' equity of at least $2,500,000. As reported on the Form 10-Q, the Company's stockholders' equity as of June 30, 2026 was $1,782,000.

  • On August 6, 2026, the board of directors (the "Board") and audit committee of the Board (the "Audit Committee") of Nexentis Technologies Inc. (the "Company") approved the dismissal of Somekh Chaikin, a member firm of KPMG International ("KPMG Israel"), as its independent registered public accounting firm, effective on August 6, 2026.

Dividend history and stock splits

Nexentis Technologies Inc. Common Stock's recent dividend payments and stock splits.

Dividends

No recent dividends.

Splits

  • 1-for-5Nov 9, 2026
  • 1-for-7Apr 8, 2026

NXTS short interest

How heavily NXTS is shorted: shares short, days to cover and average daily volume.

Days to cover
1.0
Short interest
63.64K
Avg volume
331.23K

As of · reported to FINRA twice monthly.

NXTS news

The latest news and headlines about Nexentis Technologies Inc. Common Stock (NXTS).

Frequently asked questions

What is the Nexentis Technologies Inc. Common Stock (NXTS) stock price today?

Nexentis Technologies Inc. Common Stock (NXTS) is trading at $1.83 (-8.04% on the day) as of 1:04:37 PM EST on Nov 17, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

What is Nexentis Technologies Inc. Common Stock?

Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for inflammatory metabolic diseases and…

What is the short interest in NXTS?

As of Oct 30, 2026, NXTS has 63.64K shares short and 1.0 days to cover.

What exchange is NXTS listed on?

Nexentis Technologies Inc. Common Stock (NXTS) trades on Nasdaq in USD, in the PHARMACEUTICAL PREPARATIONS industry.

Build with AI

Build an analysis of NXTS with your agent

Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.

Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a NXTS analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.

Live market data from the Massive API and MCP.Get a free API key

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.